Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Oct;30(1):62–69.

Stimulation of a human B-lymphocyte line by anti-immunoglobulin and its concanavalin A-induced suppression by a T-cell line.

T Kishimoto, P Ralph, R A Good
PMCID: PMC1541174  PMID: 304780

Abstract

The effect of anti-immunoglobulin (anti-Ig) on cultures of established human B-cell lines was studied to develop models for the initiation and regulation of immune responses. DNA synthesis in one line, BM, measured by [125I]iododeoxyuridine (IUdR) incorporation, was stimulated by anti-Ig when the continuously proliferating cultures approached high cell density. One of four lines, BJAB, was very sensitive to inhibition of DNA synthesis by anti-Ig at all cell concentrations. Of four human T-cell lines tested for suppressor activity, the CEM line was found to be activated by concanavalin A (Con A) to inhibit the anti-Ig stimulation of BM cells. No cytotoxic activity was detected in Con A-treated CEM cells. Both the anti-Ig stimulation of BM and Con A-induced suppression by CEM occurred with cloned cell lines in long-term culture, in the absence of helper or accessory cells.

Full text

PDF
62

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson J., Bullock W. W., Melchers F. Inhibition of mitogenic stimulation of mouse lymphocytes by anti-mouse immunoglobulin antibodies. I. Mode of action. Eur J Immunol. 1974 Nov;4(11):715–722. doi: 10.1002/eji.1830041103. [DOI] [PubMed] [Google Scholar]
  2. Byrt P., Ada G. L. An in vitro reaction between labelled flagellin or haemocyanin and lymphocyte-like cells from normal animals. Immunology. 1969 Oct;17(4):503–516. [PMC free article] [PubMed] [Google Scholar]
  3. Cantor H., Boyse E. A. Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J Exp Med. 1975 Jun 1;141(6):1376–1389. doi: 10.1084/jem.141.6.1376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coutinho A., Möller G. Thymus-independent B-cell induction and paralysis. Adv Immunol. 1975;21:113–236. doi: 10.1016/s0065-2776(08)60220-5. [DOI] [PubMed] [Google Scholar]
  5. Coutinho A. The theory of the 'one nonspecific signal' model for b cell activation. Transplant Rev. 1975;23:49–65. doi: 10.1111/j.1600-065x.1975.tb00148.x. [DOI] [PubMed] [Google Scholar]
  6. Dennert G., De Rose M. Continuously proliferating T killer cells specific for H-2b targets: selection and characterization. J Immunol. 1976 Jun;116(6):1601–1606. [PubMed] [Google Scholar]
  7. Greaves M. F., Bauminger S., Janossy G. Lymphocyte activation. 3. Binding sites for phytomitogens on lymphocyte subpopulations. Clin Exp Immunol. 1972 Mar;10(3):537–554. [PMC free article] [PubMed] [Google Scholar]
  8. Kearney J. F., Cooper M. D., Lawton A. R. B lymphocyte differentiation induced by lipopolysaccharide. III. Suppression of B cell maturation by anti-mouse immunoglobulin antibodies. J Immunol. 1976 Jun;116(6):1664–1668. [PubMed] [Google Scholar]
  9. Kincade P. W., Ralph P. Regulation of clonal B-lymphocyte proliferation by anti-immunoglobulin or anti-Ia antibodies. Cold Spring Harb Symp Quant Biol. 1977;41(Pt 1):245–250. doi: 10.1101/sqb.1977.041.01.030. [DOI] [PubMed] [Google Scholar]
  10. Kishimoto T., Ishizaka K. Regulation of antibody response in vitro. IX. Induction of secondary anti-hapten IgG antibody response by anti-immunoglobulin and enhancing soluble factor. J Immunol. 1975 Feb;114(2 Pt 1):585–591. [PubMed] [Google Scholar]
  11. Kishimoto T., Miyake T., Nishizawa Y., Watanabe T., Yamamura Y. Triggering mechanism of B lymphocytes. I. Effect of anti-immunoglobulin and enhancing soluble factor on differentiation and proliferation of B cells. J Immunol. 1975 Nov;115(5):1179–1184. [PubMed] [Google Scholar]
  12. Klein G., Sugden B., Leibold W., Menezes J. Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV. Intervirology. 1974;3(4):232–244. doi: 10.1159/000149760. [DOI] [PubMed] [Google Scholar]
  13. Lawton A. R., 3rd, Cooper M. D. Modification of B lymphocyte differentiation by anti-immunoglobulins. Contemp Top Immunobiol. 1974;3:193–225. doi: 10.1007/978-1-4684-3045-5_8. [DOI] [PubMed] [Google Scholar]
  14. Manning D. D. Heavy chain isotype suppression: a review of the immunosuppressive effects of heterologous anti-Ig heavy chain antisera. J Reticuloendothel Soc. 1975 Jul;18(1):63–86. [PubMed] [Google Scholar]
  15. Möller G., Sjöberg O., Andersson J. Mitogen-induced lymphocyte-mediated cytotoxicity in vitro: effect of mitogens selectively activating T or B cells. Eur J Immunol. 1972 Dec;2(6):586–592. doi: 10.1002/eji.1830020621. [DOI] [PubMed] [Google Scholar]
  16. Parker D. C. Stimulation of mouse lymphocytes by insoluble anti-mouse immunoglobulin. Nature. 1975 Nov 27;258(5533):361–363. doi: 10.1038/258361a0. [DOI] [PubMed] [Google Scholar]
  17. Raff M. C., Owen J. J., Cooper M. D., Lawton A. R., 3rd, Megson M., Gathings W. E. Differences in susceptibility of mature and immature mouse B lymphocytes to anti-immunoglobulin-induced immunoglobulin suppression in vitro. Possible implications for B-cell tolerance to self. J Exp Med. 1975 Nov 1;142(5):1052–1064. doi: 10.1084/jem.142.5.1052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ralph P., Moore M. A., Nilsson K. Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med. 1976 Jun 1;143(6):1528–1533. doi: 10.1084/jem.143.6.1528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ralph P., Nakoinz I. Inhibitory effects of lectins and lymphocyte mitogens on murine lymphomas and myelomas. J Natl Cancer Inst. 1973 Sep;51(3):883–890. doi: 10.1093/jnci/51.3.883. [DOI] [PubMed] [Google Scholar]
  20. Ralph P., Nakoinz I., Raschke W. C. Lymphosarcoma cell growth is selectively inhibited by B lymphocyte mitogens: LPS, dextran sulfate and PPD. Biochem Biophys Res Commun. 1974 Dec 23;61(4):1268–1275. doi: 10.1016/s0006-291x(74)80421-3. [DOI] [PubMed] [Google Scholar]
  21. Schmidtke J. R., Hatfield S. Activation of purified human thymus-derived (T) cells by mitogens. II. Monocyte- macrophage potentiation of mitogen-induced DNA synthesis. J Immunol. 1976 Feb;116(2):357–362. [PubMed] [Google Scholar]
  22. Sell S. A speculative comparison of allotypic suppression and allotypic blast transformation: control of expression of T and B cell immunoglobulin allotypic markers by a B cell product. Transplant Rev. 1975;27:135–156. doi: 10.1111/j.1600-065x.1975.tb00187.x. [DOI] [PubMed] [Google Scholar]
  23. Shou L., Schwartz S. A., Good R. A. Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med. 1976 May 1;143(5):1100–1110. doi: 10.1084/jem.143.5.1100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sidman C. L., Unanue E. R. Receptor-mediated inactivation of early B lymphocytes. Nature. 1975 Sep 11;257(5522):149–151. doi: 10.1038/257149a0. [DOI] [PubMed] [Google Scholar]
  25. Siegal F. P., Siegal M., Good R. A. Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemic patients. J Clin Invest. 1976 Jul;58(1):109–122. doi: 10.1172/JCI108439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tadakuma T., Kühner A. L., Rich R. R., David J. R., Pierce C. W. Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells. J Immunol. 1976 Jul;117(1):323–330. [PubMed] [Google Scholar]
  27. Tse H., Dutton R. W. Separation of helper and suppressor T lymphocytes on a ficoll velocity sedimentation gradient. J Exp Med. 1976 May 1;143(5):1199–1210. doi: 10.1084/jem.143.5.1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Waldmann T. A., Broder S., Krakauer R., MacDermott R. P., Durm M., Goldman C., Meade B. The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma. Fed Proc. 1976 Jul;35(9):2067–2072. [PubMed] [Google Scholar]
  29. Waterfield J. D., Waterfield E. M., Anaclerio A., Möller G. Lymphocyte-mediated cytotoxicity against tumor cells specificity and characterization of concanavalin A-activated cytotoxic effector lymphocytes. Transplant Rev. 1976;29:277–310. doi: 10.1111/j.1600-065x.1976.tb00205.x. [DOI] [PubMed] [Google Scholar]
  30. Weiner H. L., Moorhead J. W., Claman H. N. Anti-immunoglobulin stimulation of murine lymphocytes. I. Age dependency of the proliferative response. J Immunol. 1976 Jun;116(6):1656–1661. [PubMed] [Google Scholar]
  31. Winchester R. J., Wernet P., Kunkel H. G., Dupont B., Jersild C., Fu S. M. Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes. J Exp Med. 1975 Apr 1;141(4):924–929. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES